Ob.Gyn. News

Current Issue

February 2010 | Vol. 45 , No. 2

Top Reports

New Osteoporosis Guidelines Released

Bisphosphonates May Reduce Breast Cancer Risk, Studies Find

Aspirin Fails to Prevent Recurrent Miscarriages

Misoprostol Offers Alternative to Oxytocin for Postpartum Bleeding

Minimal EHR criteria will take effect in 2010

More Reports >>

GMNN Today's News
audio icon     Policy & Practice
video icon     Videos
Blog     EGMN Blog
      Facebook
twitter       Twitter

Colleague Commentary

Master Class
Dr. Charles E. Miller and Dr. Kevin J. Stepp discuss single-incision total laparoscopic hysterectomy, the latest innovation in minimally invasive gynecologic surgery.

Drugs, Pregnancy, and Lactation:
The newest information about anticonvulsant teratogenicity is revealed by Dr. Christina Chambers.

Daily News from Elsevier Global Medical News

View RSS feed

Activate Your Online Access to Ob.Gyn. News

Sign-up for your free access to Ob.Gyn. News online. Browse, search, and share full-text articles with colleagues and patients. For the latest news and research reports from medical meetings and expert commentary, sign up or click here for more information.

Already have a username and password? You may be asked to answer a few questions. Click here to log in.

First-time User? Create an account here, and request free access.

Purchase a print subscription now!

Request Free Access to Full-text

The Archive Collection
• Clinical Pearls
• Drugs, Pregnancy, and Lactation
• Master Class

BEST PRACTICES IN: Prenatal Screening & Cord Blood Banking Supported by PerkinElmer CLINICAL UPDATE: Women's Health and Nutrition: Demographic Challenges Supported by Xanodyne Pharmaceuticals, Inc. MORE

Clinical Perspectives in Intrauterine Contraception and Postmenopausal Hormone Therapy Supported by Bayer HealthCare Pharmaceuticals MORE

JOURNAL SCAN: The Evolution of Hysterectomy: From Dogma to Empowerment Supported by Ethicon Women's Health & Urology Clinical Perspectives on the Role of Hormone Therapy in Menopausal Management Supported by Kenwood Therapeutics, a division of Bradley Pharmaceuticals, Inc. MORE